A pilot study of intensive cyclophosphamide, epirubicin and fluorouracil in patients with axillary node positive or locally advanced breast cancer
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Oncology
Reference31 articles.
1. Adjuvant systemic therapy for early breast cancer;Henderson;Curr Probl Cancer,1987
2. Effects of adjuvant tamoxifen and of cytotoxic therapy on mortality in early breast cancer;N Engl J Med,1988
3. Combination chemotherapy (CMFVP) versus l-phenylalanine mustard (L-PAM) for operable breast cancer with positive axillary nodes;Glucksberg;Cancer,1982
4. Current status of adjuvant chemotherapy for breast cancer;Bonadonna;Semin Oncol,1987
5. Cancer of the breast;Harris,1985
Cited by 20 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Three-Year Outcomes Following Permissive Cardiotoxicity in Patients on Trastuzumab;The Oncologist;2023-04-24
2. Redefining the Incidence and Profile of Fluoropyrimidine-Associated Cardiotoxicity in Cancer Patients: A Systematic Review and Meta-Analysis;Pharmaceuticals;2023-03-30
3. Gold Nanorods@Mesoporous SiO2@Hyaluronic Acid Core–Shell Nanoparticles for Controlled Drug Delivery;ACS Applied Nano Materials;2022-04-18
4. A Phase II Study of a Dose-Density Regimen With Fluorouracil, Epirubicin, and Cyclophosphamide on Days 1 and 4 Every 14 Days With Filgrastim Support Followed by Weekly Paclitaxel in Women With Primary Breast Cancer;The Oncologist;2015-01-30
5. Chemotherapy regimens in early breast cancer: major controversies and future outlook;Expert Review of Anticancer Therapy;2013-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3